阿齐沙坦奥美沙坦酯结构式
|
常用名 | 阿齐沙坦奥美沙坦酯 | 英文名 | Azilsartan medoxomil |
|---|---|---|---|---|
| CAS号 | 863031-21-4 | 分子量 | 568.534 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 748.0±70.0 °C at 760 mmHg | |
| 分子式 | C30H24N4O8 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 406.2±35.7 °C |
阿齐沙坦奥美沙坦酯用途Azilsartan酯(TAK 491)是口服活性的1型血管紧张素II受体拮抗剂,IC50为0.62 nM。 |
| 中文名 | 阿齐沙坦奥美沙坦酯 |
|---|---|
| 英文名 | azilsartan medoxomil |
| 中文别名 | 美阿沙坦 | 1-[[2'-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1'-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基-2-氧代-1,3-二恶茂-4-基)甲酯 | 阿齐沙坦酯 | 阿奇沙坦酯 |
| 英文别名 | 更多 |
| 描述 | Azilsartan酯(TAK 491)是口服活性的1型血管紧张素II受体拮抗剂,IC50为0.62 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 748.0±70.0 °C at 760 mmHg |
| 分子式 | C30H24N4O8 |
| 分子量 | 568.534 |
| 闪点 | 406.2±35.7 °C |
| 精确质量 | 568.159424 |
| PSA | 155.59000 |
| LogP | 5.73 |
| InChIKey | QJFSABGVXDWMIW-UHFFFAOYSA-N |
| SMILES | CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1 |
| 外观性状 | 白色至米色粉末 |
| 蒸汽压 | 0.0±2.5 mmHg at 25°C |
| 折射率 | 1.680 |
| 储存条件 | -20℃ |
|
实验名称:Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HR...
来源:ChEMBL
靶标:Severe acute respiratory syndrome coronavirus 2
External Id:CHEMBL4303810
|
|
实验名称:Enzymatic assay of human HDAC6 with commercial peptide substrate
来源:ChEMBL
靶标:Histone deacetylase 6
External Id:CHEMBL4808149
|
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:Enzymatic assay of human HDAC6 with custom peptide substrate
来源:ChEMBL
靶标:Histone deacetylase 6
External Id:CHEMBL4808150
|
|
实验名称:MELAS cybrid survival enhancement under low glucose conditions
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1419
|
|
实验名称:Stabilization of p53 in human papillomavirus-positive cells
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Cellular tumor antigen p53
External Id:HMS1485
|
|
实验名称:Inhibition of cell viability relative to arbidol control (inhibition index > 1 indica...
来源:ChEMBL
靶标:Severe acute respiratory syndrome coronavirus 2
External Id:CHEMBL4303819
|
| Azilsartan kamedoxomil |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
| TAK 491 |
| azilsartanum medoxomilum |
| Azilsartan |
| (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester of 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid |
| UNII-LL0G25K7I2 |
| Azilsartan medoxomil |
| Azilsartan (medoxomil) |
| 1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester |
| Edarbi |
| [14C]-Azilsartan medoxomil |